Oppenheimer & CO Inc Becton Dickinson & CO Transaction History

Oppenheimer & CO Inc

  • $6.18 Billion
  • Q2 2024

A detailed history of Oppenheimer & CO Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Oppenheimer & CO Inc holds 21,339 shares of BDX stock, worth $5.15 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
21,339
Previous 23,501 9.2%
Holding current value
$5.15 Million
Previous $5.82 Million 14.24%
% of portfolio
0.08%
Previous 0.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
SELL
$225.07 - $246.17 $486,601 - $532,219
-2,162 Reduced 9.2%
21,339 $4.99 Million
Q1 2024

May 06, 2024
SELL
$233.45 - $247.73 $478,805 - $508,094
-2,051 Reduced 8.03%
23,501 $5.82 Million
Q4 2023

Feb 13, 2024
SELL
$232.24 - $267.23 $341,392 - $392,828
-1,470 Reduced 5.44%
25,552 $6.23 Million
Q3 2023

Nov 07, 2023
BUY
$254.9 - $283.59 $1.03 Million - $1.15 Million
4,059 Added 17.68%
27,022 $6.99 Million
Q2 2023

Aug 02, 2023
BUY
$238.39 - $265.32 $411,222 - $457,677
1,725 Added 8.12%
22,963 $6.06 Million
Q1 2023

May 10, 2023
BUY
$229.71 - $259.35 $9,188 - $10,374
40 Added 0.19%
21,238 $5.26 Million
Q4 2022

Feb 07, 2023
SELL
$218.29 - $256.91 $296,001 - $348,369
-1,356 Reduced 6.01%
21,198 $5.39 Million
Q3 2022

Nov 14, 2022
BUY
$51.03 - $264.23 $9,746 - $50,467
191 Added 0.85%
22,554 $5.03 Million
Q2 2022

Aug 08, 2022
BUY
$234.74 - $275.42 $327,931 - $384,761
1,397 Added 6.66%
22,363 $5.51 Million
Q1 2022

May 12, 2022
SELL
$243.64 - $270.48 $260,207 - $288,872
-1,068 Reduced 4.85%
20,966 $5.58 Million
Q4 2021

Feb 02, 2022
BUY
$230.08 - $250.94 $192,807 - $210,287
838 Added 3.95%
22,034 $5.54 Million
Q3 2021

Nov 12, 2021
BUY
$232.72 - $256.47 $98,673 - $108,743
424 Added 2.04%
21,196 $5.21 Million
Q2 2021

Aug 03, 2021
BUY
$232.65 - $254.58 $28,150 - $30,804
121 Added 0.59%
20,772 $5.05 Million
Q1 2021

May 10, 2021
SELL
$232.09 - $256.88 $491,798 - $544,328
-2,119 Reduced 9.31%
20,651 $5.02 Million
Q4 2020

Feb 11, 2021
SELL
$221.92 - $245.94 $45,049 - $49,925
-203 Reduced 0.88%
22,770 $5.7 Million
Q3 2020

Nov 13, 2020
BUY
$215.77 - $276.76 $53,510 - $68,636
248 Added 1.09%
22,973 $5.35 Million
Q2 2020

Aug 11, 2020
BUY
$219.9 - $263.41 $451,454 - $540,780
2,053 Added 9.93%
22,725 $5.44 Million
Q1 2020

May 08, 2020
SELL
$195.69 - $279.01 $73,775 - $105,186
-377 Reduced 1.79%
20,672 $4.75 Million
Q4 2019

Feb 07, 2020
BUY
$236.45 - $266.82 $485,904 - $548,315
2,055 Added 10.82%
21,049 $5.73 Million
Q3 2019

Oct 31, 2019
SELL
$230.58 - $256.08 $65,484 - $72,726
-284 Reduced 1.47%
18,994 $4.81 Million
Q2 2019

Aug 09, 2019
BUY
$217.4 - $246.08 $31,305 - $35,435
144 Added 0.75%
19,278 $4.86 Million
Q1 2019

Apr 24, 2019
SELL
$206.05 - $248.17 $1.12 Million - $1.35 Million
-5,452 Reduced 22.18%
19,134 $4.78 Million
Q4 2018

Jan 29, 2019
SELL
$204.73 - $257.93 $898,150 - $1.13 Million
-4,387 Reduced 15.14%
24,586 $5.54 Million
Q3 2018

Oct 26, 2018
SELL
$233.07 - $256.0 $413,000 - $453,632
-1,772 Reduced 5.76%
28,973 $7.56 Million
Q2 2018

Aug 10, 2018
SELL
$208.1 - $233.85 $48,487 - $54,487
-233 Reduced 0.75%
30,745 $7.37 Million
Q1 2018

May 01, 2018
SELL
$205.46 - $240.27 $304,491 - $356,080
-1,482 Reduced 4.57%
30,978 $6.71 Million
Q4 2017

Feb 07, 2018
SELL
$189.0 - $222.64 $186,543 - $219,745
-987 Reduced 2.95%
32,460 $6.95 Million
Q3 2017

Nov 09, 2017
BUY
$186.89 - $198.9 $6.25 Million - $6.65 Million
33,447
33,447 $6.55 Million

Others Institutions Holding BDX

# of Institutions
1,733
Shares Held
252M
Call Options Held
586K
Put Options Held
649K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email